Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

A woman developed lupus after taking hydroxyurea for two years.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The ointment is a safe, effective, and well-tolerated treatment for certain types of psoriasis.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Ciproterone acetate improves hair regrowth and acne in most female patients.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Juläine injections safely improve hair regrowth in men and women with pattern hair loss.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Using ultrasound to guide temple filler injections improves safety and accuracy.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.